文献速递神经肿瘤功能神经外科

清醒开颅术后单药与双药抗癫痫发作药物管理对术后癫痫控制的对比分析

Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
PubMed 文献 · J Neurosurg · 2017-06-16

该回顾性分析纳入2007至2015年由单一术者完成的81例清醒开颅脑肿瘤切除患者,比较单药与双药抗癫痫发作药物(ASD)管理的术后癫痫控制效果。双药组术后癫痫发生率低于单药组(5.7% vs 21.7%,p=0.044),6个月随访Engel I级比例更高(90% vs 60%,p=0.027),90天再入院率更低(8.5% vs 26.1%,p=0.044)。多因素分析显示术前癫痫史是术后癫痫的显著预测因素(OR 2.08,95%CI 0.56-0.90,p<0.001)。

要点

  • 双药组术后癫痫发生率5.7%,低于单药组的21.7%(p=0.044)。
  • 双药组6个月Engel I级比例90%,高于单药组的60%(p=0.027)。
  • 术前癫痫史是术后癫痫的显著预测因素(OR 2.08,95%CI 0.56-0.90,p<0.001)。

核心结论

  • 有术前癫痫史的患者在清醒开颅术后可能面临更高的术后癫痫风险,并可能从术后ASD双药治疗带来的更好癫痫控制中获益。

研究设计与样本

  • 回顾性分析2007至2015年由单一术者完成的81例清醒开颅脑肿瘤切除患者数据,分为单药ASD组和双药ASD组,比较人口学、症状、肿瘤特征、住院详情及癫痫结局,并用多因素logistic回归评估与术后癫痫相关的临床变量。

主要发现

  • 术后癫痫发生率单药组为21.7%,双药组为5.7%(p=0.044)。
  • 6个月随访Engel I级(无癫痫发作)比例双药组为90%,单药组为60%(p=0.027)。
  • 住院时长单药组为4.02天,双药组为4.51天(p=0.193)。
  • 90天再入院率单药组为26.1%,双药组为8.5%(p=0.044)。
  • 多因素logistic回归显示术前癫痫史是清醒开颅术后癫痫的显著预测因素(OR 2.08,95%CI 0.56-0.90,p<0.001)。

临床怎么用

  • 作者认为,有术前癫痫史的患者在清醒开颅术后可能面临更高的术后癫痫风险,并可能从术后ASD双药治疗带来的更好癫痫控制中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Postoperative seizures are a common complication in patients undergoing an awake craniotomy, given the cortical manipulation during tumor resection and the electrical cortical stimulation for brain mapping. However, little evidence exists about the efficacy of postoperative seizure prophylaxis. This study aims to determine the most appropriate antiseizure drug (ASD) management regimen following an awake craniotomy. METHODS The authors performed a retrospective analysis of data pertaining to patients who underwent an awake craniotomy for brain tumor from 2007 to 2015 performed by a single surgeon. Patients were divided into 2 groups, those who received a single ASD (the monotherapy group) and those who received 2 types of ASDs (the duotherapy group). Patient demographics, symptoms, tumor characteristics, hospitalization details, and seizure outcome were evaluated. Multivariable logistic regression was used to evaluate numerous clinical variables associated with postoperative seizures. RESULTS A total of 81 patients underwent an awake craniotomy for tumor resection of an eloquent brain lesion. Preoperative baseline characteristics were comparable between the 2 groups. The postoperative seizure rate was 21.7% in the monotherapy group and 5.7% in the duotherapy group (p = 0.044). Seizure outcome at 6 months' follow-up was assessed with the Engel classification scale. The duotherapy group had a significantly higher proportion of seizure-free (Engel Class I) patients than the monotherapy group (90% vs 60%, p = 0.027). The length of stay was similar, 4.02 days in the monotherapy group and 4.51 days in the duotherapy group (p = 0.193). The 90-day readmission rate was higher for the monotherapy group (26.1% vs 8.5% in the duotherapy group, p = 0.044). Multivariate logistic regression showed that preoperative seizure history was a significant predictor for postoperative seizures following an awake craniotomy (OR 2.08, 95% CI 0.56-0.90, p < 0.001). CONCLUSIONS Patients with a preoperative seizure history may be at a higher risk for postoperative seizures following an awake craniotomy and may benefit from better postoperative seizure control with postoperative ASD duotherapy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Eseonu CI, Eguia F, Garcia O, et al. Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy. J Neurosurg. 2017. PMID: 28621631. doi:10.3171/2017.1.JNS162913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。